Beta version of the DAISHO PIM software tool released
Beta version available for interested users who want to try out the new functionality and improvements of the DAISHO 4.1 “Sync Release”
Juniper Secures Apple iPad for Mobile Enterprises
Juniper Extends Industry-Leading Junos® Pulse Platform to Enable Secure iPad Access to Corporate Resources
Gartner Says Worldwide Semiconductor Market to Grow 4.6 Per Cent as Revenue Reaches $314 Billion in 2011
Semiconductor Market Surpassing Landmark $300 Billion in Revenue in 2010
Gartner Says Master Data Management Is Important in a Tough Economy, and Even More Important in a Growth Economy
Analysts to discuss future for Master Data Management at the Gartner Master Data Management Summit 2011, 2-3 February, in London
Hotel Construction in the Arabian Gulf continuously on course for growth
Analysis by tophotelprojects.com – Financial crisis gently overcome
Brazil Insists on Environmental Considerations in Certification of Batteries and Cells
Brazil has passed Settlement CONAMA no. 401/08 into law as of July 2009, tightening controls on the composition of batteries and cells and in particular on their final disposal.
BÜRGEL Country Information
BÜRGEL puts the most important international corporate forms online free of charge
EU Project SmartCoDe: Exacting efficient implementation of intelligent energy management systems
Focus on smart local energy grids
Gartner Says Worldwide Sales of Connected E-Readers on Track to Reach 6.6 Million Units in 2010
.2010 – Worldwide connected e-reader sales to end users are forecast to total 6.6 million units in 2010, up 79.8 per cent from 2009 sales of 3.6 million units, according to Gartner, Inc. In 2011, worldwide e-reader sales are projected to surpass 11 million units, a 68.3 per cent increase from 2010.
The market for e-reading devices – portable devices that use an E Ink, e-paper or similar display technology – has become crowded and is at risk of commoditisation due to developments in adjac
AiCuris completes Phase II genital herpes trial with AIC316 ahead of time
AiCuris announced today that the last subject has completed their Phase-II trial "A double-blind randomized placebo controlled dose-finding trial to investigate different doses of a new antiviral drug in subjects with genital HSV Type 2 infection".
The trial has been completed two months earlier than planned. Indeed, in the later stages of the trial, enrolment had to be restricted as the number of subjects was higher than the number that was required to be enrolled according t